Effects of SMAC Mimetic BV6 on Immune Cells
Author Information
Author(s): Müller-Sienerth Nicole, Dietz Lena, Holtz Philipp, Kapp Markus, Grigoleit Götz Ulrich, Schmuck Carsten, Wajant Harald, Siegmund Daniela
Primary Institution: University Hospital Würzburg
Hypothesis
How does the SMAC mimetic BV6 affect immune cells, particularly monocytes and dendritic cells?
Conclusion
BV6 induces cell death in monocytes while promoting maturation of dendritic cells.
Supporting Evidence
- BV6 treatment resulted in a significant increase in annexin-V positive cells in monocytes.
- BV6 induced maturation of dendritic cells as indicated by upregulation of CD83 and CD86.
- Monocytes showed a strong reduction in viability when treated with BV6.
Takeaway
BV6 is a compound that can kill certain immune cells called monocytes but helps other immune cells called dendritic cells to grow and mature.
Methodology
Monocytes were isolated from blood and treated with BV6 to assess cell death and maturation effects.
Potential Biases
Potential bias in donor variability and the specific immune cell types studied.
Limitations
The study primarily focuses on in vitro effects, which may not fully represent in vivo responses.
Participant Demographics
Freshly isolated human monocytes from buffy coats of anonymous donors.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website